Switch theme
Sign up to access all valuation multiples
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
1980
5.5K+
LTM Revenue $1.5B
LTM EBITDA $368M
$7.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Stevanato Group has a last 12-month revenue (LTM) of $1.5B and a last 12-month EBITDA of $368M.
In the most recent fiscal year, Stevanato Group achieved revenue of $1.1B and an EBITDA of $248M.
Stevanato Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Stevanato Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | XXX | $1.1B | XXX | XXX | XXX |
| Gross Profit | $436M | XXX | $302M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 27% | XXX | XXX | XXX |
| EBITDA | $368M | XXX | $248M | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 22% | XXX | XXX | XXX |
| EBIT | $247M | XXX | $161M | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $174M | XXX | $118M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $314M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 17, 2025, Stevanato Group's stock price is $26.
Stevanato Group has current market cap of $7.0B, and EV of $7.3B.
See Stevanato Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7.3B | $7.0B | XXX | XXX | XXX | XXX | $0.57 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 17, 2025, Stevanato Group has market cap of $7.0B and EV of $7.3B.
Stevanato Group's trades at 6.6x EV/Revenue multiple, and 29.5x EV/EBITDA.
Equity research analysts estimate Stevanato Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Stevanato Group has a P/E ratio of 47.1x.
See valuation multiples for Stevanato Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7.0B | XXX | $7.0B | XXX | XXX | XXX |
| EV (current) | $7.3B | XXX | $7.3B | XXX | XXX | XXX |
| EV/Revenue | 5.7x | XXX | 6.6x | XXX | XXX | XXX |
| EV/EBITDA | 23.4x | XXX | 29.5x | XXX | XXX | XXX |
| EV/EBIT | 34.9x | XXX | 45.4x | XXX | XXX | XXX |
| EV/Gross Profit | 19.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 47.1x | XXX | 59.2x | XXX | XXX | XXX |
| EV/FCF | -72.6x | XXX | -46.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialStevanato Group's last 12 month revenue growth is 12%
Stevanato Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $26K for the same period.
Stevanato Group's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stevanato Group's rule of X is 54% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Stevanato Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 37% | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 54% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $26K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Stevanato Group acquired XXX companies to date.
Last acquisition by Stevanato Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Stevanato Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Stevanato Group founded? | Stevanato Group was founded in 1980. |
| Where is Stevanato Group headquartered? | Stevanato Group is headquartered in United States of America. |
| How many employees does Stevanato Group have? | As of today, Stevanato Group has 5.5K+ employees. |
| Who is the CEO of Stevanato Group? | Stevanato Group's CEO is Mr. Franco Stevanato. |
| Is Stevanato Group publicy listed? | Yes, Stevanato Group is a public company listed on NYS. |
| What is the stock symbol of Stevanato Group? | Stevanato Group trades under STVN ticker. |
| When did Stevanato Group go public? | Stevanato Group went public in 2021. |
| Who are competitors of Stevanato Group? | Similar companies to Stevanato Group include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Stevanato Group? | Stevanato Group's current market cap is $7.0B |
| What is the current revenue of Stevanato Group? | Stevanato Group's last 12 months revenue is $1.5B. |
| What is the current revenue growth of Stevanato Group? | Stevanato Group revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Stevanato Group? | Current revenue multiple of Stevanato Group is 5.7x. |
| Is Stevanato Group profitable? | Yes, Stevanato Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Stevanato Group? | Stevanato Group's last 12 months EBITDA is $368M. |
| What is Stevanato Group's EBITDA margin? | Stevanato Group's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Stevanato Group? | Current EBITDA multiple of Stevanato Group is 23.4x. |
| What is the current FCF of Stevanato Group? | Stevanato Group's last 12 months FCF is -$119M. |
| What is Stevanato Group's FCF margin? | Stevanato Group's last 12 months FCF margin is -8%. |
| What is the current EV/FCF multiple of Stevanato Group? | Current FCF multiple of Stevanato Group is -72.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
